Stock listing
BSE:CIPLA Cipla Ltd Share Price
Indian listing (BSE) of Cipla Ltd · home listing NSE:CIPLA
Follow Cipla Ltd into a list and get an email when it puts out news.
Home listing price · NSE:CIPLA
₹1,415.00 INR -2.00 (-0.1%)
Close on Nov 20, 2026 · This listing has no price on 6ix; the price shown is the home listing's, NSE:CIPLA
- Day range
- ₹1,401.20 – ₹1,428.00 INRNov 20, 2026
- Volume
- 1.48M sharesNov 20, 2026
- Market cap
- ₹1.14T INRAt the close on Nov 20, 2026 · price × 807.9M shares outstanding
- 52-week range
- ₹1,165.70 – ₹1,539.70 INRLowest and highest trades, Nov 21, 2025 – Nov 20, 2026
- Traded on an average day
- ₹1.54B INRMedian day 1.01M shares · last 3 months, Aug 20, 2026 – Nov 20, 2026

Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| NSE:CIPLA · Home | ₹1,415.00 INR | -2.00 (-0.1%) | 1,484,426 | ₹1,418.50 | ₹1,428.00 | ₹1,401.20 | ₹1,417.00 | Close on Nov 20, 2026 |
Daily closes
Last 3 months, Aug 20, 2026 – Nov 20, 2026 · NSE:CIPLA · INR, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| ₹1,415.00 | -2.00 | -0.1% | ₹1,418.50 | ₹1,428.00 | ₹1,401.20 | 1,484,426 | |
| ₹1,417.00 | +29.00 | +2.1% | ₹1,390.00 | ₹1,435.00 | ₹1,381.30 | 2,909,024 | |
| ₹1,388.00 | -6.50 | -0.5% | ₹1,390.00 | ₹1,399.40 | ₹1,383.00 | 1,017,376 | |
| ₹1,394.50 | +2.70 | +0.2% | ₹1,393.00 | ₹1,406.00 | ₹1,389.00 | 1,248,691 | |
| ₹1,391.80 | -16.50 | -1.2% | ₹1,407.00 | ₹1,418.70 | ₹1,391.80 | 1,022,855 | |
| ₹1,408.30 | -11.60 | -0.8% | ₹1,413.60 | ₹1,420.00 | ₹1,399.50 | 1,683,740 | |
| ₹1,419.90 | +16.10 | +1.1% | ₹1,415.80 | ₹1,420.20 | ₹1,406.10 | 1,723,204 | |
| ₹1,403.80 | -7.20 | -0.5% | ₹1,408.00 | ₹1,421.40 | ₹1,397.50 | 1,706,347 | |
| ₹1,411.00 | +6.90 | +0.5% | ₹1,387.00 | ₹1,411.00 | ₹1,382.00 | 1,567,019 | |
| ₹1,404.10 | +2.10 | +0.1% | ₹1,405.00 | ₹1,408.00 | ₹1,390.20 | 1,226,346 | |
| ₹1,402.00 | +5.10 | +0.4% | ₹1,391.70 | ₹1,402.00 | ₹1,386.00 | 1,322,399 | |
| ₹1,396.90 | +9.90 | +0.7% | ₹1,382.20 | ₹1,396.90 | ₹1,370.50 | 1,723,192 | |
| ₹1,387.00 | +8.10 | +0.6% | ₹1,383.00 | ₹1,391.00 | ₹1,364.60 | 1,377,336 | |
| ₹1,378.90 | +20.90 | +1.5% | ₹1,362.00 | ₹1,381.70 | ₹1,357.00 | 1,436,661 | |
| ₹1,358.00 | -7.60 | -0.6% | ₹1,357.70 | ₹1,372.50 | ₹1,347.00 | 1,141,230 | |
| ₹1,365.60 | +15.60 | +1.2% | ₹1,335.20 | ₹1,368.20 | ₹1,327.10 | 997,121 | |
| ₹1,350.00 | -5.00 | -0.4% | ₹1,352.10 | ₹1,372.70 | ₹1,319.00 | 4,078,811 | |
| ₹1,355.00 | +17.00 | +1.3% | ₹1,336.60 | ₹1,360.00 | ₹1,330.00 | 1,548,428 | |
| ₹1,338.00 | +7.10 | +0.5% | ₹1,332.40 | ₹1,338.00 | ₹1,314.10 | 1,323,900 | |
| ₹1,330.90 | +16.90 | +1.3% | ₹1,302.00 | ₹1,330.90 | ₹1,296.40 | 638,943 | |
| ₹1,314.00 | -10.10 | -0.8% | ₹1,324.10 | ₹1,337.50 | ₹1,308.30 | 1,238,869 | |
| ₹1,324.10 | -1.00 | -0.1% | ₹1,322.00 | ₹1,339.00 | ₹1,321.60 | 1,387,215 | |
| ₹1,325.10 | -2.90 | -0.2% | ₹1,335.00 | ₹1,337.50 | ₹1,315.10 | 850,284 | |
| ₹1,328.00 | +13.40 | +1.0% | ₹1,311.60 | ₹1,336.40 | ₹1,310.60 | 1,371,747 | |
| ₹1,314.60 | -15.00 | -1.1% | ₹1,333.30 | ₹1,333.30 | ₹1,302.70 | 994,166 | |
| ₹1,329.60 | +18.30 | +1.4% | ₹1,315.00 | ₹1,329.60 | ₹1,303.00 | 478,066 | |
| ₹1,311.30 | +10.30 | +0.8% | ₹1,307.40 | ₹1,317.40 | ₹1,300.20 | 666,122 | |
| ₹1,301.00 | -5.80 | -0.4% | ₹1,310.50 | ₹1,316.40 | ₹1,295.30 | 653,621 | |
| ₹1,306.80 | -20.40 | -1.5% | ₹1,323.20 | ₹1,334.20 | ₹1,292.00 | 551,708 | |
| ₹1,327.20 | -13.00 | -1.0% | ₹1,338.50 | ₹1,351.00 | ₹1,324.70 | 847,901 | |
| ₹1,340.20 | +4.70 | +0.4% | ₹1,335.00 | ₹1,344.90 | ₹1,323.20 | 575,696 | |
| ₹1,335.50 | -8.50 | -0.6% | ₹1,334.30 | ₹1,337.70 | ₹1,321.00 | 1,084,209 | |
| ₹1,344.00 | -2.00 | -0.1% | ₹1,349.10 | ₹1,359.40 | ₹1,333.40 | 921,789 | |
| ₹1,346.00 | -33.30 | -2.4% | ₹1,383.00 | ₹1,384.00 | ₹1,346.00 | 1,063,964 | |
| ₹1,379.30 | -4.40 | -0.3% | ₹1,390.00 | ₹1,401.80 | ₹1,376.20 | 1,479,526 | |
| ₹1,383.70 | -16.00 | -1.1% | ₹1,399.70 | ₹1,405.00 | ₹1,380.50 | 711,020 | |
| ₹1,399.70 | +0.70 | +0.1% | ₹1,402.90 | ₹1,421.00 | ₹1,388.40 | 1,166,527 | |
| ₹1,399.00 | +16.00 | +1.2% | ₹1,375.00 | ₹1,419.00 | ₹1,364.60 | 1,580,784 | |
| ₹1,383.00 | -1.10 | -0.1% | ₹1,382.40 | ₹1,387.00 | ₹1,371.80 | 651,221 | |
| ₹1,384.10 | -2.00 | -0.1% | ₹1,386.30 | ₹1,388.70 | ₹1,364.50 | 767,139 | |
| ₹1,386.10 | -8.40 | -0.6% | ₹1,383.20 | ₹1,405.20 | ₹1,378.30 | 895,131 | |
| ₹1,394.50 | +18.20 | +1.3% | ₹1,371.70 | ₹1,394.50 | ₹1,371.70 | 1,386,584 | |
| ₹1,376.30 | +18.30 | +1.3% | ₹1,362.50 | ₹1,385.00 | ₹1,351.60 | 730,653 | |
| ₹1,358.00 | +7.00 | +0.5% | ₹1,351.00 | ₹1,363.70 | ₹1,344.30 | 911,572 | |
| ₹1,351.00 | -15.00 | -1.1% | ₹1,355.00 | ₹1,362.70 | ₹1,347.70 | 1,225,305 | |
| ₹1,366.00 | -7.30 | -0.5% | ₹1,373.00 | ₹1,373.00 | ₹1,347.70 | 1,681,155 | |
| ₹1,373.30 | +10.20 | +0.7% | ₹1,366.80 | ₹1,380.00 | ₹1,363.10 | 826,221 | |
| ₹1,363.10 | -20.90 | -1.5% | ₹1,380.00 | ₹1,388.70 | ₹1,363.10 | 818,773 | |
| ₹1,384.00 | -11.00 | -0.8% | ₹1,393.40 | ₹1,398.40 | ₹1,377.20 | 728,795 | |
| ₹1,395.00 | +10.00 | +0.7% | ₹1,380.00 | ₹1,395.70 | ₹1,376.80 | 606,497 | |
| ₹1,385.00 | -9.70 | -0.7% | ₹1,397.70 | ₹1,399.10 | ₹1,375.50 | 1,326,180 | |
| ₹1,394.70 | -18.10 | -1.3% | ₹1,414.00 | ₹1,415.40 | ₹1,389.40 | 549,749 | |
| ₹1,412.80 | -10.20 | -0.7% | ₹1,414.00 | ₹1,417.00 | ₹1,401.20 | 578,260 | |
| ₹1,423.00 | +13.80 | +1.0% | ₹1,420.90 | ₹1,425.70 | ₹1,406.50 | 880,100 | |
| ₹1,409.20 | -14.30 | -1.0% | ₹1,418.00 | ₹1,426.10 | ₹1,409.20 | 977,929 | |
| ₹1,423.50 | +3.50 | +0.2% | ₹1,420.00 | ₹1,423.90 | ₹1,409.10 | 377,976 | |
| ₹1,420.00 | +17.30 | +1.2% | ₹1,405.00 | ₹1,420.00 | ₹1,402.10 | 533,212 | |
| ₹1,402.70 | -19.30 | -1.4% | ₹1,413.50 | ₹1,419.40 | ₹1,401.10 | 915,493 | |
| ₹1,422.00 | -15.90 | -1.1% | ₹1,435.90 | ₹1,435.90 | ₹1,411.10 | 799,235 | |
| ₹1,437.90 | +5.70 | +0.4% | ₹1,428.00 | ₹1,442.30 | ₹1,410.30 | 1,220,646 | |
| ₹1,432.20 | -5.80 | -0.4% | ₹1,433.40 | ₹1,443.60 | ₹1,408.60 | 728,275 | |
| ₹1,438.00 | +16.00 | +1.1% | ₹1,430.00 | ₹1,439.40 | ₹1,427.50 | 327,752 |
Splits
3 splits since 1999 · NSE:CIPLA · every price before a split is adjusted for it
| Day | Ratio | What |
|---|---|---|
| 5-for-2 | Split | |
| 5-for-1 | Split | |
| 3-for-1 | Split |
- Ticker
- BSE:CIPLA
- Asset type
- Stock
- Sector
- Health care
- Industry
- Pharmaceuticals
- Exchange
- BSE
- Currency
- INR
What changed lately
Latest news release · Oct 27, 2026
Cipla Limited has informed the Exchange regarding a press release dated October 27, 2026, titled "Q2FY27 Financial Results".
Latest deck · Oct 27, 2026
Q2 FY27 Earnings Presentation
Earnings · 17 slides
Latest news
Cipla Limited has informed the Exchange regarding a press release dated October 27, 2026, titled "Q2FY27 Financial Results".
Oct 27, 2026
Closed ₹1,350.00 (-0.4%) on Oct 27, 2026
Cipla Announces Exclusive Partnership with Qilu Pharmaceutical for the Licensing and Supply of Biosimilar to Keytruda in the US
Sep 4, 2026
Closed ₹1,395.00 (+0.7%) on Sep 7, 2026
Cipla Announces Exclusive Partnership with Qilu Pharmaceutical for the Licensing and Supply of Biosimilar to Keytruda® (Pembrolizumab) in the US
Sep 3, 2026
Closed ₹1,385.00 (-0.7%) on Sep 4, 2026
Cipla Ltd Press Release Aug 31 2026
Aug 31, 2026
Closed ₹1,409.20 (-1.0%) on Aug 31, 2026
Cipla Ltd Press Release Jul 23 2026
Jul 23, 2026
Closed ₹1,395.00 (-1.5%) on Jul 23, 2026
Press Release May 13 2026
May 13, 2026
Closed ₹1,329.80 (+2.8%) on May 13, 2026
Cipla Receives U.S. FDA Approval for First AB-Rated Generic of Ventolin HFA
Apr 24, 2026
Closed ₹1,296.00 (-0.8%) on Apr 24, 2026
Cipla Expands U.S. Respiratory Portfolio with Approval of Nintedanib Capsules (100mg & 150mg) for Idiopathic Pulmonary Fibrosis
Apr 2, 2026
Closed ₹1,203.90 (+0.7%) on Apr 6, 2026
Cipla strengthens US portfolio with the launch of generic Saxenda(R) (Liraglutide Injection) for weight management therapy
Mar 2, 2026
Closed ₹1,313.00 (-2.8%) on Mar 4, 2026
Cipla strengthens US portfolio with the launch of generic Saxenda for weight management therapy
Mar 2, 2026
Closed ₹1,313.00 (-2.8%) on Mar 4, 2026
Cipla Ltd on 6ix
- Sector
- Health care
- Industry
- Pharmaceuticals
- News releases
- 13 in the last 12 months · 93 in all · newest Oct 27, 2026 · oldest 2020
- Decks
- 81 decks · latest Oct 27, 2026
Where Cipla Ltd is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| NSE:CIPLA · Home listing | NSE | India | INR |
| BSE:CIPLA · This page | BSE | India | INR |
| LUXSE:CIPLA | LUXSE | Luxembourg | USD |
| Turquoise:CIPLGX | Turquoise | United Kingdom | USD |
Valuation
P/E 39.5× against a median of 41.4×: 5th lowest of 10 Pharmaceuticals companies shown. Statements: 4 quarters to Sep 30, 2026 · price Nov 20, 2026
- Enterprise value
- ₹1.04T INR
- P/E
- 39.5×
- EV/sales
- 3.7×
- EV/EBITDA
- 21.6×
- Price/book
- 3.2×
- Gross margin
- 57.1%
- Operating margin
- 12.6%
- Net margin
- 10.4%
- Debt to equity
- 0.0×
- Beta
- No index for this market yet
Pharmaceuticals: the 10 companies nearest in size, of 492 on 6ix with figures. Size in US dollars.
| Company | Mkt cap | EV | P/E | EV/Sales | EV/EBITDA | P/B | Net mgn | Debt/Eq | Beta |
|---|---|---|---|---|---|---|---|---|---|
| Cipla Ltd · NSE:CIPLA | US$12.34B | US$11.26B | 39.5× | 3.7× | 21.6× | 3.2× | 10.4% | 0.0× | n/a |
| Yunnan Baiyao Group Co. Ltd. Class A · SZSE:000538 | US$15.07B | US$13.10B | 19.4× | 2.0× | n/a | 2.5× | 12.2% | 0.0× | n/a |
| Jazz Pharmaceuticals plc · NASDAQ:JAZZ | US$14.95B | US$18.48B | 72.6× | 3.9× | n/a | 3.6× | 4.4% | 1.3× | 0.64 |
| Ipsen SA · EURONEXT:IPN | US$14.62B | US$13.51B | 30.0× | 3.4× | 11.2× | 2.8× | 12.1% | 0.2× | n/a |
| Laurus Labs Ltd. · NSE:LAURUSLABS | US$13.38B | US$13.66B | 92.5× | 16.2× | 53.2× | 20.5× | 17.1% | 0.4× | n/a |
| Zydus Lifesciences Limited · NSE:ZYDUSLIFE | US$12.92B | US$13.86B | 28.6× | 4.2× | 17.9× | 4.3× | 13.8% | 0.5× | n/a |
| Elanco Animal Health Incorporated · NYSE:ELAN | US$12.87B | US$15.85B | n/a | 3.1× | 13.1× | 1.9× | −2.9% | 0.5× | 1.20 |
| Dr. Reddy's Laboratories Ltd. · NSE:DRREDDY | US$12.50B | US$12.45B | 41.4× | 3.5× | 22.6× | 3.0× | 8.5% | 0.2× | n/a |
| Mankind Pharma Ltd. · NSE:MANKIND | US$11.88B | US$12.18B | 49.1× | 7.3× | 27.7× | 6.3× | 14.6% | 0.3× | n/a |
| Zhangzhou Pientzehuang Pharmaceutical Co., Ltd. Class A · SSE:600436 | US$11.62B | US$11.29B | 58.9× | 9.5× | n/a | 5.5× | 16.7% | 0.0× | n/a |
| Aurobindo Pharma Ltd · NSE:AUROPHARMA | US$11.17B | US$11.02B | 25.9× | 2.8× | 13.4× | 2.6× | 10.8% | 0.2× | n/a |
| Median of the others | US$12.89B | US$13.31B | 41.4× | 3.7× | 17.9× | 3.3× | 12.1% | 0.3× | 0.92 |
Forecasts
Analysts' consensus from EODHD, read Nov 9, 2026. Not 6ix's view and not investment advice.
- Price target
- 1507.31 INR · Analysts' mean
- EPS, year to Mar 2027
- 48.70 · 35 analysts
- Revenue, year to Mar 2027
- 305.6B · 35 analysts
Team and board
Officers
| Officer | Role |
|---|---|
| Achin Gupta | Managing Director & Global Chief Executive Officer |
| Paul Miller | CEO Cipla South Africa & Regional Head Africa and Access |
| Shivam Puri | CEO - One India Business |
| Swapn Malpani | CEO – Emerging Markets and Europe |
| Dinesh Jain | Global Chief Financial Officer |
| Meera Vanjari | Chief General Counsel (Global) |
| Arun Kakatkar | Global Chief People Officer |
| Jaideep Gogtay | Global Chief Medical Officer |
| Marc Falkin | CEO - North America |
| Prabhakaran Nair | Global Chief Manufacturing Officer |
| Sai Mungara | Global Head Supply Chain |
| Sneha Hiranandani | Chief Information Officer |
| Sushrut Kulkarni | Global Chief- Integrated Product Development (IPD) |
Board
| Director | Role |
|---|---|
| Abhijit Joshi | Non-Executive Director |
| Adil Zainulbhai | Non-Executive Director |
| Balram Bhargava | Independent Director |
| Mandar Vaidya | Independent Director |
| Maya Hari | Independent Director |
| Rashmi Joshi | Independent Director |
Events
- Next results
- Jan 21, 2027 (expected)
| Quarter | Results | Share move |
|---|---|---|
| Q2 2027 | Oct 27, 2026 · Before open | −0.4% |
| Q1 2027 | Jul 23, 2026 · Before open | −1.5% |
| Q4 2026 | May 13, 2026 · Before open | +2.8% |
| Q3 2026 | Jan 23, 2026 · Before open | −3.8% |
| Q2 2026 | Oct 30, 2025 · Before open | −2.5% |
| Q1 2026 | Jul 25, 2025 · Before open | +3.3% |
| Q4 2025 | May 13, 2025 · Before open | +0.8% |
| Q3 2025 | Jan 28, 2025 · Before open | +2.2% |
| Q2 2025 | Oct 29, 2024 · Before open | −1.9% |
| Q1 2025 | Jul 26, 2024 · Before open | +5.6% |
All 20 quarters
| Quarter | Results | Share move |
|---|---|---|
| Q4 2024 | May 10, 2024 · Before open | −1.9% |
| Q3 2024 | Jan 22, 2024 · Before open | +7.2% |
| Q2 2024 | Oct 27, 2023 · Before open | +2.1% |
| Q1 2024 | Jul 26, 2023 · Before open | +2.3% |
| Q4 2023 | May 12, 2023 · After close | −1.1% |
| Q3 2023 | Jan 25, 2023 · Before open | −2.1% |
| Q2 2023 | Nov 4, 2022 · Before open | −1.6% |
| Q1 2023 | Jul 29, 2022 · Before open | +1.1% |
| Q4 2022 | May 10, 2022 · Before open | −1.2% |
| Q3 2022 | Jan 25, 2022 · Before open | +1.1% |
Decks
| Deck | Kind | Slides | Date |
|---|---|---|---|
| Q2 FY27 Earnings Presentation | Earnings | 17 slides | Oct 27, 2026 |
| Q1 FY27 Earnings Presentation | Earnings | 15 slides | Jul 23, 2026 |
| Q4 FY26 Earnings Presentation | Earnings | 22 slides | May 13, 2026 |
| Q3 FY26 Earnings Presentation | Earnings | 17 slides | Jan 23, 2026 |
| Q2 FY26 Earnings Presentation | Earnings | 18 slides | Oct 30, 2025 |
| Q2 FY2026 Earnings Presentation | Earnings | 17 slides | Oct 30, 2025 |
| Q1 FY26 Earnings Presentation | Earnings | 17 slides | Jul 25, 2025 |
| Q1 FY2026 Earnings Presentation | Earnings | 16 slides | Jul 25, 2025 |
| Shareholder Meeting (July 2025) | Shareholder meeting | 18 slides | Jul 16, 2025 |
| Q4 FY25 Earnings Presentation | Earnings | 23 slides | May 13, 2025 |
Show 50 decks
This page holds 50 of 81 decks. Open Decks
Financials
Annual, in INR
Income statement
| Line | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 281.6B | 272.7B | 255.4B | 225.6B | 217.1B | 191.2B | 170.8B | 163.2B | 151.1B | 143.3B |
| Cost of revenue | 161.3B | 91.8B | 90.4B | 84.6B | 86.9B | 75.1B | 61.5B | 59.3B | 55.2B | 52.2B |
| Gross profit | 120.4B | 180.9B | 164.9B | 141.0B | 130.2B | 116.1B | 109.3B | 103.9B | 95.9B | 91.1B |
| Research and development | 5.21B | 14.8B | 15.2B | 12.9B | 2.66B | 1.33B | 3.56B | 3.60B | 2.70B | 2.81B |
| Selling, general and administrative | 30.9B | 49.4B | 44.0B | 39.2B | 36.1B | 33.3B | 31.0B | 30.0B | 28.1B | 27.5B |
| Operating income | 47.1B | 105.0B | 94.8B | 78.0B | 80.9B | 73.5B | 67.1B | 62.9B | 59.0B | 55.3B |
| Depreciation and amortization | 12.1B | 9.95B | 9.39B | 11.7B | 9.90B | 10.0B | 11.7B | 11.0B | 9.50B | 8.71B |
| EBITDA | 59.2B | 115.0B | 104.2B | 89.7B | 90.8B | 83.6B | 78.8B | 73.9B | 68.5B | 64.0B |
| Interest expense | 543.9M | 620.1M | 785.1M | 1.10B | 911.6M | 1.46B | 1.90B | 1.68B | 1.14B | 1.59B |
| Income before tax | 52.2B | 68.0B | 57.0B | 40.4B | 34.8B | 32.8B | 21.3B | 20.6B | 16.7B | 12.2B |
| Income tax | 13.5B | 15.3B | 15.5B | 12.0B | 9.34B | 8.89B | 6.31B | 5.70B | 2.50B | 1.80B |
| Net income | 38.8B | 52.7B | 41.2B | 28.0B | 25.2B | 24.0B | 15.5B | 15.3B | 14.1B | 10.1B |
| Earnings per share, basic | 48.00 | 65.24 | 51.01 | 34.69 | 31.17 | 29.79 | 19.16 | 18.93 | 17.50 | 12.50 |
Balance sheet
| Line | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 10.2B | 5.89B | 6.40B | 6.28B | 6.78B | 7.93B | 7.42B | 5.08B | 8.53B | 6.10B |
| Short-term investments | 90.1B | 100.2B | 71.4B | 56.4B | 39.5B | 29.5B | 2.50B | 1.01B | 1.02B | 37.8M |
| Receivables | 60.1B | 55.1B | 47.7B | 40.6B | 34.2B | 34.5B | 38.9B | 41.5B | 31.0B | 25.6B |
| Inventory | 66.0B | 56.4B | 52.4B | 51.6B | 53.5B | 46.7B | 43.8B | 39.6B | 40.4B | 34.9B |
| Current assets | 241.5B | 232.9B | 194.4B | 172.7B | 147.1B | 132.1B | 117.0B | 124.3B | 108.1B | 88.0B |
| Property, plant and equipment | 64.8B | 59.3B | 56.8B | 56.1B | 56.5B | 56.7B | 55.1B | 58.3B | 57.3B | |
| Goodwill | 37.5B | 32.7B | 31.1B | 29.8B | 31.4B | 30.1B | 29.3B | 28.7B | 28.1B | 27.0B |
| Total assets | 425.0B | 373.9B | 327.2B | 294.6B | 271.0B | 251.5B | 236.6B | 239.6B | 228.6B | 210.4B |
| Accounts payable | 32.3B | 28.4B | 24.7B | 25.3B | 25.1B | 20.7B | 22.8B | 19.5B | 21.2B | 15.7B |
| Current liabilities | 70.1B | 54.8B | 52.5B | 51.1B | 49.1B | 45.9B | 43.9B | 37.7B | 38.3B | 33.7B |
| Long-term debt | 1.17B | 119.8M | 0 | 0 | 4.16B | 12.0B | 23.7B | 38.3B | 36.6B | 36.5B |
| Total debt | 6.14B | 4.39B | 5.60B | 8.03B | 10.6B | 20.2B | 31.1B | 43.2B | 41.0B | 41.1B |
| Total liabilities | 79.8B | 61.0B | 59.2B | 57.5B | 59.8B | 65.7B | 76.1B | 86.2B | 82.8B | 80.6B |
| Shareholders' equity | 344.3B | 311.9B | 267.1B | 234.1B | 208.4B | 183.3B | 157.6B | 150.1B | 142.3B | 125.4B |
| Shares outstanding | 808.2M | 808.2M | 808.0M | 807.6M | 807.4M | 807.3M | 807.1M | 806.8M | 806.1M | 805.3M |
Cash flow
| Line | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash from operations | 41.3B | 50.0B | 41.3B | 32.4B | 33.3B | 37.6B | 30.7B | 16.9B | 14.6B | 23.8B |
| Capital spending | -16.0B | -11.6B | -13.5B | -11.8B | -7.01B | -8.19B | -10.0B | -5.27B | -8.16B | -11.4B |
| Free cash flow | 25.3B | 38.4B | 27.8B | 20.5B | 26.2B | 29.4B | 20.7B | 11.6B | 6.47B | 12.5B |
| Cash from investing | -25.3B | -36.9B | -29.9B | -23.9B | -18.7B | -23.9B | 1.04B | -16.7B | -8.54B | -13.1B |
| Cash from financing | -12.1B | -12.9B | -12.0B | -9.58B | -16.0B | -12.4B | -29.5B | -3.49B | -3.85B | -13.3B |
| Dividends paid | -12.9B | -10.5B | -6.86B | -4.04B | -4.03B | -360.0M | -5.64B | -2.42B | -1.61B | -1.61B |
| Share buybacks | 500.0K | 400.0K | -5.07B | -1.33B | -360.0M | 242.0M | -1.11B | 1.20M | -10.1B | |
| Change in cash | 6.89B | 303.1M | -489.9M | -967.8M | -1.32B | 505.8M | 2.34B | -3.45B | 2.43B | -2.48B |
Filings
| Filing | Date | Type | Filed with |
|---|---|---|---|
| Cipla Limited has informed the Exchange regarding a press release dated October 27, 2026, titled "Q2FY27 Financial Results". | Oct 27, 2026 | Results | NSE India |
| Cipla Ltd Press Release Aug 31 2026 | Aug 31, 2026 | Operations update | NSE India |
| Cipla Ltd Press Release Jul 23 2026 | Jul 23, 2026 | Results | NSE India |
| Press Release May 13 2026 | May 13, 2026 | Results | NSE India |
| Press Release Jan 23 2026 | Jan 23, 2026 | Results | NSE India |
| Press Release Oct 30 2025 | Oct 30, 2025 | Other filings | NSE India |
| Press Release Jul 25 2025 | Jul 25, 2025 | Results | NSE India |
| Press Release May 13 2025 | May 13, 2025 | Results | NSE India |
| Press Release Jan 28 2025 | Jan 28, 2025 | Other filings | NSE India |
| Press Release Oct 29 2024 | Oct 29, 2024 | Other filings | NSE India |
All 76 filings
| Filing | Date | Type | Filed with |
|---|---|---|---|
| Press Release Jul 26 2024 | Jul 26, 2024 | Other filings | NSE India |
| Press Release Jun 18 2024 | Jun 18, 2024 | Other filings | NSE India |
| Press Release May 10 2024 | May 10, 2024 | Other filings | NSE India |
| Press Release Mar 26 2024 | Mar 26, 2024 | Other filings | NSE India |
| Press Release Jan 22 2024 | Jan 22, 2024 | Other filings | NSE India |
| Press Release Jan 08 2024 | Jan 8, 2024 | Other filings | NSE India |
| Press Release (Revised) Dec 15 2023 | Dec 15, 2023 | Legal or regulatory action | NSE India |
| Press Release Dec 14 2023 | Dec 14, 2023 | Acquisition or disposal | NSE India |
| Cipla Ltd Press Release Dec 10 2023 | Dec 9, 2023 | Other filings | NSE India |
| Press Release Oct 27 2023 | Oct 27, 2023 | Other filings | NSE India |
| Press Release Sep 04 2023 | Sep 4, 2023 | Acquisition or disposal | NSE India |
| Press Release Jul 26 2023 | Jul 26, 2023 | Other filings | NSE India |
| Press Release Jul 07 2023 | Jul 7, 2023 | Other filings | NSE India |
| Press Release May 12 2023 | May 12, 2023 | Other filings | NSE India |
| Press Release Jan 25 2023 | Jan 25, 2023 | Other filings | NSE India |
| Cipla Ltd Press Release Jan 18 2023 | Jan 17, 2023 | Operations update | NSE India |
| Press Release Dec 30 2022 | Dec 30, 2022 | Other filings | NSE India |
| Press Release Nov 29 2022 | Nov 29, 2022 | Operations update | NSE India |
| Press Release Nov 04 2022 | Nov 4, 2022 | Other filings | NSE India |
| Press Release Oct 11 2022 | Oct 11, 2022 | Operations update | NSE India |
| Press Release Sep 07 2022 | Sep 7, 2022 | Other filings | NSE India |
| Press Release Jul 29 2022 | Jul 29, 2022 | Other filings | NSE India |
| Press Release Jul 14 2022 | Jul 14, 2022 | Acquisition or disposal | NSE India |
| Press Release Jun 27 2022 | Jun 27, 2022 | Other filings | NSE India |
| Press Release Jun 17 2022 | Jun 17, 2022 | Other filings | NSE India |
| Press Release Jun 14 2022 | Jun 14, 2022 | Operations update | NSE India |
| Press Release Jun 02 2022 | Jun 2, 2022 | Other filings | NSE India |
| Press Release May 25 2022 | May 25, 2022 | Other filings | NSE India |
| Press Release May 10 2022 | May 10, 2022 | Other filings | NSE India |
| Press Release Jan 25 2022 | Jan 25, 2022 | Other filings | NSE India |
| Press Release Jan 13 2022 | Jan 13, 2022 | Other filings | NSE India |
| Press Release Dec 28 2021 | Dec 28, 2021 | Operations update | NSE India |
| Press Release Dec 18 2021 | Dec 18, 2021 | Other filings | NSE India |
| Press Release Dec 15 2021 | Dec 15, 2021 | Acquisition or disposal | NSE India |
| Press Release Nov 17 2021 | Nov 17, 2021 | Operations update | NSE India |
| Press Release Nov 15 2021 | Nov 15, 2021 | Other filings | NSE India |
| Press Release Oct 26 2021 | Oct 26, 2021 | Other filings | NSE India |
| Press Release Oct 04 2021 | Oct 4, 2021 | Other filings | NSE India |
| Press Release Aug 25 2021 | Aug 25, 2021 | Other filings | NSE India |
| Press Release Aug 12 2021 | Aug 12, 2021 | Other filings | NSE India |
| Press Release Aug 05 2021 | Aug 5, 2021 | Other filings | NSE India |
| Press Release Jun 29 2021 | Jun 29, 2021 | Operations update | NSE India |
| Press Release Jun 23 2021 | Jun 23, 2021 | Operations update | NSE India |
| Press Release Jun 15 2021 | Jun 15, 2021 | Other filings | NSE India |
| Press Release May 24 2021 | May 24, 2021 | Other filings | NSE India |
| Press Release May 20 2021 | May 20, 2021 | Operations update | NSE India |
| Press Release May 14 2021 | May 14, 2021 | Results | NSE India |
| Press Release May 10 2021 | May 10, 2021 | Other filings | NSE India |
| Press Release May 05 2021 | May 5, 2021 | Other filings | NSE India |
| Press Release Apr 28 2021 | Apr 28, 2021 | Other filings | NSE India |
| Press Release Mar 23 2021 | Mar 23, 2021 | Other filings | NSE India |
| Press Release Mar 18 2021 | Mar 18, 2021 | Other filings | NSE India |
| Press Release Mar 02 2021 | Mar 2, 2021 | Operations update | NSE India |
| Press Release Jan 29 2021 | Jan 29, 2021 | Other filings | NSE India |
| Press Release Jan 27 2021 | Jan 27, 2021 | Operations update | NSE India |
| Press Release Dec 18 2020 | Dec 18, 2020 | Other filings | NSE India |
| Press Release Dec 16 2020 | Dec 16, 2020 | Operations update | NSE India |
| Press Release Dec 11 2020 | Dec 11, 2020 | Other filings | NSE India |
| Press Release Nov 18 2020 | Nov 18, 2020 | Operations update | NSE India |
| Press Release Nov 06 2020 | Nov 6, 2020 | Other filings | NSE India |
| Press Release Oct 28 2020 | Oct 28, 2020 | Other filings | NSE India |
| Press Release Oct 20 2020 | Oct 20, 2020 | Operations update | NSE India |
| Press Release Oct 12 2020 | Oct 12, 2020 | Other filings | NSE India |
| Press Release Sep 25 2020 | Sep 25, 2020 | Other filings | NSE India |
| Press Release Aug 20 2020 | Aug 20, 2020 | Other filings | NSE India |
| Press Release Aug 07 2020 | Aug 7, 2020 | Results | NSE India |
Cap table
Built by 6ix from Cipla Ltd’s releases
- Common shares
- 807,870,615
- Fully diluted
- 807,870,615
Fully diluted
| Line | Shares |
|---|---|
| Common shares | 807,870,615 |
Share count over time
| Count | Shares |
|---|---|
| Nov 22, 2026 | 807,870,615 |
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Abhijit Joshi | Non-Executive Director · Since at least Nov 6, 2026 |
| Achin Gupta | Managing Director & Global Chief Executive Officer · Since at least Sep 4, 2026 |
| Adil Zainulbhai | Non-Executive Director · Since at least Nov 6, 2026 |
| Arun Kakatkar | Global Chief People Officer · Since at least Nov 6, 2026 |
| Balram Bhargava | Independent Director · Since at least Nov 6, 2026 |
| Dinesh Jain | Global Chief Financial Officer · Since at least Nov 6, 2026 |
| Jaideep Gogtay | Global Chief Medical Officer · Since at least Nov 6, 2026 |
| Mandar Vaidya | Independent Director · Since at least Nov 6, 2026 |
| Marc Falkin | CEO - North America · Since at least Sep 4, 2026 |
| Maya Hari | Independent Director · Since at least Nov 6, 2026 |
All 19 people
| Person | Seat |
|---|---|
| Meera Vanjari | Chief General Counsel (Global) · Since at least Nov 6, 2026 |
| Paul Miller | CEO Cipla South Africa & Regional Head Africa and Access · Since at least Nov 6, 2026 |
| Prabhakaran Nair | Global Chief Manufacturing Officer · Since at least Nov 6, 2026 |
| Rashmi Joshi | Independent Director · Since at least Nov 6, 2026 |
| Sai Mungara | Global Head Supply Chain · Since at least Nov 6, 2026 |
| Shivam Puri | CEO - One India Business · Since at least Nov 6, 2026 |
| Sneha Hiranandani | Chief Information Officer · Since at least Nov 6, 2026 |
| Sushrut Kulkarni | Global Chief- Integrated Product Development (IPD) · Since at least Nov 6, 2026 |
| Swapn Malpani | CEO – Emerging Markets and Europe · Since at least Nov 6, 2026 |
Log in to ask 6ix AI your own questions about Cipla Ltd.